Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2015 | 1 |
2016 | 1 |
2017 | 1 |
2018 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
Approaches to manage 'affordability' of high budget impact medicines in key EU countries.
J Mark Access Health Policy. 2018 Jun 8;6(1):1478539. doi: 10.1080/20016689.2018.1478539. eCollection 2018.
J Mark Access Health Policy. 2018.
PMID: 29915664
Free PMC article.
Review.
Early Insights from Commercialization of Gene Therapies in Europe.
Touchot N, Flume M.
Touchot N, et al.
Genes (Basel). 2017 Feb 17;8(2):78. doi: 10.3390/genes8020078.
Genes (Basel). 2017.
PMID: 28218692
Free PMC article.
Item in Clipboard
Feasibility and attractiveness of indication value-based pricing in key EU countries.
Flume M, Bardou M, Capri S, Sola-Morales O, Cunningham D, Levin LA, Touchot N; Payers’ Insight.
Flume M, et al. Among authors: touchot n.
J Mark Access Health Policy. 2016 May 10;4. doi: 10.3402/jmahp.v4.30970. eCollection 2016.
J Mark Access Health Policy. 2016.
PMID: 27226845
Free PMC article.
Review.
Item in Clipboard
The payers' perspective on gene therapies.
Touchot N, Flume M.
Touchot N, et al.
Nat Biotechnol. 2015 Sep;33(9):902-4. doi: 10.1038/nbt.3332.
Nat Biotechnol. 2015.
PMID: 26348952
No abstract available.
Item in Clipboard
Cite
Cite